Bifidobacterium breve 207-1 and use thereof
AssigneeByhealth Co., Ltd.
InventorsXiaolei Ze, Xuguang Zhang, Ruikun He, Fang He
Life of this patent
Estimating the term…
Abstract
The present application relates to a Bifidobacterium breve or progeny thereof. Specifically, the present application relates to Bifidobacterium breve 207-1 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Bifidobacterium breve 207-1 and the composition, culture, food product or dietary supplement containing the same in medicine.
Claims14
A food product comprising Bifldobacierium breve accession no. GDMCC No. 60962, deposited in Guangdong Microbial Culture Collection Center, or progeny thereof, and an additive, wherein the additive is selected from the group consisting of a dietary fiber, prebiotic, protein, lipid, plant polyphenol, or any combmation thereof.
A pharmaceutical composition comprising a pharmaceutically effective amount of Bifidobacterium breve accession no. GDMCC No. 60962 and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is in the form of a pill, powder, capsule, tablet, granulate material, sachet or dragee, and wherein one dose of the composition comprises 106 to 1012 CFU/dose or 108 to 1012 CFU/dose.
A microbial culture comprising Bifidobacterium breve accession no. GDMCC No. 60962 and a second microorganism, wherein the second microorganism is selected from the group consisting of a different bacterium, a fungus and a yeast.
Dependencies are inferred from the claim text.